Mitochondrial Energy Production in ART (Assisted Reproductive Technology )
NCT ID: NCT02727400
Last Updated: 2018-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2017-04-01
2018-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.
NCT03639506
Automitochondrial Transplantation Improves Live Birth in Elderly Patients With Low Prognosis After Repeated IVF Failure
NCT06020742
Improving the Reproductive Outcome of Poor Quality Ova by Injection of Autologous Somatic Mitochondria
NCT01631578
Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation
NCT05372549
To Evaluate The Anrogens and Ovary Function in In Vitro Fertilization
NCT01600794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
advanced maternal age
Infertile women due to advanced maternal age
No interventions assigned to this group
Young patients
women under 35 undergoing infertility treatments
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cases: infertile women undergoing IVF due to advanced maternal age (\>38 years)
Exclusion Criteria
* Severe hypersensitivity to drugs of similar structure
* Be positive in serology for syphilis, toxoplasmosis, rubella, gonorrhea, hepatitis B, hepatitis C and HIV and lack of personal history and family of hereditary diseases.
Cases
* Irregular cycles
* Previous Ovarian surgery
* Previous chemotherapy or radiotherapy
18 Years
46 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IVI Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan A Garcia-Velasco, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
IVI Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI Madrid
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1512-MAD-064-JGPROTOCOLOf-151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.